Recent Progress in the Development of Selective TRPV1 Antagonists for Pain

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|8|16|1431-1441

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.8, Iss.16, 2008-11, pp. : 1431-1441

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Screening TRPV1 antagonists for the treatment of pain: lessons learned over a decade

By Lázár József   Gharat Laxmikant   Khairathkar-Joshi Neelima   Blumberg Peter M   Szallasi Arpad  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 2, 2009-02 ,pp. : 159-180

Informa Healthcare

Access to resources Recommend Favorite

Recent Progress in the Development of Agonists and Antagonists for Melatonin Receptors

By  

Current Medicinal Chemistry, Vol. 19, Iss. 21, 2012-07 ,pp. : 3532-3549

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders

By Buzard Daniel J   Thatte Jayant   Lerner Michael   Edwards Jeffrey   Jones Robert M  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 10, 2008-10 ,pp. : 1141-1159

Informa Healthcare

Access to resources Recommend Favorite

TRPV1: On the Road to Pain Relief

By  

Current Molecular Pharmacology, Vol. 1, Iss. 3, 2008-11 ,pp. : 255-269

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4

By Pease James Edward   Horuk Richard  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 5, 2014-05 ,pp. : 467-483

Informa Healthcare

Access to resources Recommend Favorite